***********************************
Brakke Consulting’s
Animal Health News & Notes for June 19, 2015
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
************************************
IN THE NEWS:
Brakke Consulting news
AnimalHealthJobs.com
other news
Animal Health International
Biogal Galed Labs
Modern Veterinary Therapeutics
Patterson
Petco
Putney
Quincy Bioscience
Vétoquinol
Vets Plus
Zoetis
***********************************
2015 KC Animal Health Corridor Homecoming & Investment Forum
August 31 – September 1, 2015
Registration is now open
Celebrate 10 years with the KC Animal Health Corridor at the 2015 Homecoming Dinner on Monday, August 31 at the Kansas City Convention Center. Kansas City Royals’ General Manager Dayton Moore will be the Keynote Speaker. To register, go to http://www.eventbrite.com/e/kc-animal-health-corridor-homecoming-dinner-2015-tickets-16992385683.
Then, join us on Tuesday, September 1 for the world’s only full-day investment forum dedicated exclusively to the animal health industry. To register, go to http://www.eventbrite.com/e/kc-animal-health-corridor-investment-forum-2015-tickets-16992760805.
For more information, contact Kimberly Young at Young@thinkkc.com .
http://kcanimalhealth.thinkkc.com/
***********************************
COMPANY NEWS RELEASES
> Putney, Inc. announced that its Tiletamine-Zolazepam injectable, the only FDA-approved generic of Zoetis’ Telazol, is now commercially available. (company press release)
> Vets Plus announced it will begin distributing Quincy Bioscience’s Neutricks cognitive products for aging dogs and cats. The line currently includes a tablet for dogs and powder for cats. Vets Plus will also begin manufacturing Neutricks in an easy-to-give soft chew for dogs. (company press release)
> Patterson Companies announced that it has successfully completed the previously announced acquisition of Animal Health International, Inc. Patterson Companies financed the acquisition through a combination of a $1 billion unsecured term loan and a $500 million unsecured cash flow revolving line of credit. Animal Health International generated sales of $1.5 billion during the 12 months ended March 2015. (Streetinsider.com)
> Petco announced it is launching an on-demand delivery service in partnership with Instacart that can deliver products to customers in as little as one hour. The service, which is available in select cities, is accessible a web portal and mobile app. (Bizjournals.com)
> UK Zoetis has announced the UK launch of Contacera (meloxicam) oral suspension for horses. Contacera can be mixed with food or syringed directly into the mouth; Contacera solution for injection is also available. (Vetsurgeon.org)
> EU The Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion for Vétoquinol’s UpCard tablets (torasemide). UpCard, a diuretic, is indicated to treat clinical signs, including edema and effusion, related to canine congestive heart failure. (Animal Pharm)
> CANADA Modern Veterinary Therapeutics, LLC announced that the Canadian Veterinary Drugs Directorate (VDD) has approved Hymatil (tilmicosin injection). Hymatil is indicated for the treatment of bovine respiratory disease (BRD) and for the reduction of morbidity associated with bovine respiratory disease (BRD) in feedlot calves. Hymatil is also indicated for the treatment of pneumonic pasteurellosis in lambs. (company press release)
> ISRAEL Biogal Galed Labs announced the launch of the Canine Babesia canis and Canine Parvovirus PCRun molecular detection test kits. With Biogal’s PCRun, vets can receive a PCR result within 75 minutes. (company press release)
***********************************
ANIMAL HEALTH NEWS
> US – SWINE VIRUS Researchers at the Virginia-Maryland College of Veterinary Medicine have isolated a novel virus affecting young piglets and also isolated from swine blood meal, an ingredient in pig feed. The virus, called mammalian orthoreovirus 3 (MRV3), may be contributing to intestinal infections currently affecting the swine population in the US and other countries. (Animal Pharm)
> US – MUMS GRANT The FDA announced the opening date for applications for grants to support the development of new animal drugs intended for minor species or minor uses in major species (major species are horses, dogs, cats, cattle, pigs, turkeys and chickens). This is a new Funding Opportunity Announcement (#RFA-FD-15-004). Applications must be submitted electronically by August 14, 2015, through www.grants.gov. For more information, go to http://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm451719.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery (FDA)
***********************************
ANIMALHEALTHJOBS.COM
The best place on the web to find qualified job applicants!
AnimalHealthJobs.com is now in its 9th year of operation. It has become an exceptional and mature capability for your recruiting efforts.
AnimalHealthJobs.com has grown to include over 27,000 pre-qualified job seekers, and consistently maintains a high degree of talent: 66% of our registered users have a Bachelor’s degree, and 21% have some kind of advanced degree.
AnimalHealthJobs.com recently achieved a new record for the number of job postings on the site, with 139 job postings, so when you are seeking the best, come to www.AnimalHealthJobs.com – first.
www.AnimalHealthJobs.com
************************************
BRAKKE CONSULTING VIEWPOINT
This week’s news covers a number of product approvals and launches from both large and small firms. Most of these product announcements are for generic products and not new innovative products to grow the market.
While there are indications from several sources that the market is growing in double digits the first few months of 2015, those estimates do not seem to match with the financial reports of the public companies that make up a large percentage of the total industry revenue. We believe that 2015 will be a growth year for the industry but continue to be concerned over the increased pricing on leading brands and generic competition. Our recently published Pet Pharmaceutical Study would indicate that value or price is driving some pet owners to the OTC markets.
Have a great weekend!
Ron Brakke
**********************************
This electronic newsletter is the sole property of Brakke Consulting, Inc.
Any use of the contents herein should be approved by and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services and syndicated studies, visit our website at www.brakkeconsulting.com.
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX 75234 USA
English (United States) 
Portuguese